A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma

Results from the longitudinal population-based PROFILES registry in the south of the Netherlands

S. Oerlemans, F. Mols, D.E. Issa, J.F.M. Pruijt, W.G. Peters, M.L. Lybeert, W.P. Zijlstra, J.W.W. Coebergh, L.V. van de Poll-Franse

Research output: Contribution to journalArticleScientificpeer-review

115 Downloads (Pure)

Abstract

The course of fatigue and quality of life in survivors of non-Hodgkin's lymphoma is unknown. The aims of this study were, therefore, to assess fatigue and quality of life in patients with non-Hodgkin's lymphoma following primary treatment, compare fatigue and quality of life in these patients with those of an age- and sex matched normative population to assess the severity of concerns and identify associations with fatigue of survivors who remained fatigued. The population-based Eindhoven Cancer Registry was used to select all patients diagnosed with non-Hodgkin's lymphoma from 1999-2009. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire and the Fatigue Assessment Scale were completed once by 824 survivors of non-Hodgkin's lymphoma (80% response rate); 434 survivors completed these questionnaires again 1 year later. Survivors of non-Hodgkin's lymphoma reported more clinically relevant fatigue up till 10 years post-diagnosis compared to a normative population (P<0.001). Mean fatigue scores remained fairly stable over time (T1: x=28, SD=26; T2: x=30, SD=27, P=0.14): 22-28% of survivors reported deterioration, 19-23% reported improvement and 44-54% reported constant fatigue. Survivors who reported constant fatigue were more often diagnosed with stage IV disease and had more comorbid diseases. They were additionally more often female and divorced. Having comorbidities and being without a partner were also associated with constant fatigue in the normative population. In conclusion, six out of every ten responding non-Hodgkin's lymphoma survivors reported a high level of fatigue up till 10 years after diagnosis. Mean fatigue scores remained stable over time and survivors reporting constant fatigue more often had stage IV disease at diagnosis and comorbidities.
Original languageEnglish
Pages (from-to)479-486
JournalHaematologica
Volume98
Issue number3
DOIs
Publication statusPublished - 2013

Fingerprint

Netherlands
Non-Hodgkin's Lymphoma
Survivors
Comorbidity
Divorce
Neoplasms
Organizations

Cite this

Oerlemans, S. ; Mols, F. ; Issa, D.E. ; Pruijt, J.F.M. ; Peters, W.G. ; Lybeert, M.L. ; Zijlstra, W.P. ; Coebergh, J.W.W. ; van de Poll-Franse, L.V. / A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma : Results from the longitudinal population-based PROFILES registry in the south of the Netherlands. In: Haematologica. 2013 ; Vol. 98, No. 3. pp. 479-486.
@article{7e7312b276bb4fc693c223cbaafd1437,
title = "A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma: Results from the longitudinal population-based PROFILES registry in the south of the Netherlands",
abstract = "The course of fatigue and quality of life in survivors of non-Hodgkin's lymphoma is unknown. The aims of this study were, therefore, to assess fatigue and quality of life in patients with non-Hodgkin's lymphoma following primary treatment, compare fatigue and quality of life in these patients with those of an age- and sex matched normative population to assess the severity of concerns and identify associations with fatigue of survivors who remained fatigued. The population-based Eindhoven Cancer Registry was used to select all patients diagnosed with non-Hodgkin's lymphoma from 1999-2009. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire and the Fatigue Assessment Scale were completed once by 824 survivors of non-Hodgkin's lymphoma (80{\%} response rate); 434 survivors completed these questionnaires again 1 year later. Survivors of non-Hodgkin's lymphoma reported more clinically relevant fatigue up till 10 years post-diagnosis compared to a normative population (P<0.001). Mean fatigue scores remained fairly stable over time (T1: x=28, SD=26; T2: x=30, SD=27, P=0.14): 22-28{\%} of survivors reported deterioration, 19-23{\%} reported improvement and 44-54{\%} reported constant fatigue. Survivors who reported constant fatigue were more often diagnosed with stage IV disease and had more comorbid diseases. They were additionally more often female and divorced. Having comorbidities and being without a partner were also associated with constant fatigue in the normative population. In conclusion, six out of every ten responding non-Hodgkin's lymphoma survivors reported a high level of fatigue up till 10 years after diagnosis. Mean fatigue scores remained stable over time and survivors reporting constant fatigue more often had stage IV disease at diagnosis and comorbidities.",
author = "S. Oerlemans and F. Mols and D.E. Issa and J.F.M. Pruijt and W.G. Peters and M.L. Lybeert and W.P. Zijlstra and J.W.W. Coebergh and {van de Poll-Franse}, L.V.",
year = "2013",
doi = "10.3324/haematol.2012.064907",
language = "English",
volume = "98",
pages = "479--486",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "3",

}

A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma : Results from the longitudinal population-based PROFILES registry in the south of the Netherlands. / Oerlemans, S.; Mols, F.; Issa, D.E.; Pruijt, J.F.M.; Peters, W.G.; Lybeert, M.L.; Zijlstra, W.P.; Coebergh, J.W.W.; van de Poll-Franse, L.V.

In: Haematologica, Vol. 98, No. 3, 2013, p. 479-486.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - A high level of fatigue among long-term survivors of non-Hodgkin's lymphoma

T2 - Results from the longitudinal population-based PROFILES registry in the south of the Netherlands

AU - Oerlemans, S.

AU - Mols, F.

AU - Issa, D.E.

AU - Pruijt, J.F.M.

AU - Peters, W.G.

AU - Lybeert, M.L.

AU - Zijlstra, W.P.

AU - Coebergh, J.W.W.

AU - van de Poll-Franse, L.V.

PY - 2013

Y1 - 2013

N2 - The course of fatigue and quality of life in survivors of non-Hodgkin's lymphoma is unknown. The aims of this study were, therefore, to assess fatigue and quality of life in patients with non-Hodgkin's lymphoma following primary treatment, compare fatigue and quality of life in these patients with those of an age- and sex matched normative population to assess the severity of concerns and identify associations with fatigue of survivors who remained fatigued. The population-based Eindhoven Cancer Registry was used to select all patients diagnosed with non-Hodgkin's lymphoma from 1999-2009. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire and the Fatigue Assessment Scale were completed once by 824 survivors of non-Hodgkin's lymphoma (80% response rate); 434 survivors completed these questionnaires again 1 year later. Survivors of non-Hodgkin's lymphoma reported more clinically relevant fatigue up till 10 years post-diagnosis compared to a normative population (P<0.001). Mean fatigue scores remained fairly stable over time (T1: x=28, SD=26; T2: x=30, SD=27, P=0.14): 22-28% of survivors reported deterioration, 19-23% reported improvement and 44-54% reported constant fatigue. Survivors who reported constant fatigue were more often diagnosed with stage IV disease and had more comorbid diseases. They were additionally more often female and divorced. Having comorbidities and being without a partner were also associated with constant fatigue in the normative population. In conclusion, six out of every ten responding non-Hodgkin's lymphoma survivors reported a high level of fatigue up till 10 years after diagnosis. Mean fatigue scores remained stable over time and survivors reporting constant fatigue more often had stage IV disease at diagnosis and comorbidities.

AB - The course of fatigue and quality of life in survivors of non-Hodgkin's lymphoma is unknown. The aims of this study were, therefore, to assess fatigue and quality of life in patients with non-Hodgkin's lymphoma following primary treatment, compare fatigue and quality of life in these patients with those of an age- and sex matched normative population to assess the severity of concerns and identify associations with fatigue of survivors who remained fatigued. The population-based Eindhoven Cancer Registry was used to select all patients diagnosed with non-Hodgkin's lymphoma from 1999-2009. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire and the Fatigue Assessment Scale were completed once by 824 survivors of non-Hodgkin's lymphoma (80% response rate); 434 survivors completed these questionnaires again 1 year later. Survivors of non-Hodgkin's lymphoma reported more clinically relevant fatigue up till 10 years post-diagnosis compared to a normative population (P<0.001). Mean fatigue scores remained fairly stable over time (T1: x=28, SD=26; T2: x=30, SD=27, P=0.14): 22-28% of survivors reported deterioration, 19-23% reported improvement and 44-54% reported constant fatigue. Survivors who reported constant fatigue were more often diagnosed with stage IV disease and had more comorbid diseases. They were additionally more often female and divorced. Having comorbidities and being without a partner were also associated with constant fatigue in the normative population. In conclusion, six out of every ten responding non-Hodgkin's lymphoma survivors reported a high level of fatigue up till 10 years after diagnosis. Mean fatigue scores remained stable over time and survivors reporting constant fatigue more often had stage IV disease at diagnosis and comorbidities.

UR - http://hdl.handle.net/10411/10205

U2 - 10.3324/haematol.2012.064907

DO - 10.3324/haematol.2012.064907

M3 - Article

VL - 98

SP - 479

EP - 486

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 3

ER -